Short- and Long-term Outcomes of Surgical Treatment of Active Infective Endocarditis
-
摘要:
目的 回顾性分析北京协和医院71例活动期感染性心内膜炎(active infective endocarditis, AIE)患者手术治疗的近远期疗效。 方法 2001年1月至2010年7月, 根据杜克诊断标准(Duke criteria)共确诊感染性心内膜炎(infective endocarditis, IE)209例, 78例接受了手术治疗, 选择其中71例活动期感染性心内膜炎患者的临床资料, 进行回顾性分析; 排除病例包括同期人工瓣膜感染性心内膜炎和愈合期心内膜炎。 结果 71例活动期感染性心内膜炎患者的平均年龄为(44.6±14.4)岁, 其中男性55例(77.5%)。链球菌是最常见的致病菌。术后住院期间死亡2例(2.8%)。平均随访时间(42.4±32.4)个月(1~126个月), 1、5和10年实际生存率分别为(98.5±1.5)%、(92.6±4.5)%和(79.4±12.8)%。 结论 手术治疗活动期感染性心内膜炎的近远期临床疗效满意。 -
关键词:
- 活动期感染性心内膜炎 /
- 手术治疗
Abstract:Objective To analyze the short- and long-term outcomes of surgical treatment of active infective endocarditis(IE). Methods Surgeries were performed for 71 patients with active IE from January 2001 to July 2010. Patients with prosthetic valve or healed IE were excluded. Results Of these 71 patients, the mean age was 44.6±14.4 years, and 55(77.5%) were men. Streptococcus was the most common causative microorganism. Two patients (2.8%) died during post-surgical hospital stay. Survivors were followed up for 42.4±32.4 months. The actuarial 1-, 5-, and 10-year survival rates were (98.5±1.5)%, (92.6±4.5)%, and (79.4±12.8)%, respectively. Conclusion Surgery can achieve satisfactory short- and long-term effectiveness for active IE. -
Key words:
- active infective endocarditis /
- surgery
-
表 1 微生物培养结果
-
[1] Tornos P, Iung B, Permanyer-Miralda G, et al.Infective endocarditis in Europe:lessons from the Euro heart survey[J].Heart, 2005, 91:571-575. doi: 10.1136/hrt.2003.032128 [2] Cabell CH, Abrutyn E, Fowler VG Jr, et al.International Collaboration on Endocarditis Merged Database (ICE-MD) Study Group Investigators.Use of surgery in patients with native valve infective endocarditis:results from the International Collaboration on Endocarditis Merged Database[J].Am Heart J, 2005, 150:1092-1098. doi: 10.1016/j.ahj.2005.03.057 [3] David T, Gavra G, Feindel C, et al.Surgical treatment of active infective endocarditis:a continued challenge[J].J Thorac Cardiovasc Surg, 2007, 133:144-149. doi: 10.1016/j.jtcvs.2006.08.060 [4] The Society of Thoracic Surgeons.STS Adultcardiac surgery database data definitions[DB/OL].[2009-01-19].http://www.sts.org/sections/stsnationaldatabase/datamanagers/adultcardiacdb/datacollection/index.html2005. [5] Beynon RP, Bahl VK, Prendergast BD.Infective endocarditis[J].BMJ, 2006, 333:334-339. doi: 10.1136/bmj.333.7563.334 [6] Alexiou C, Langley SM, Stafford H, et al.Surgery for active culture-positive endocarditis:determinants of early and late outcome[J].Ann Thorac Surg, 2000, 69:1448-1454. doi: 10.1016/S0003-4975(00)01139-5 [7] Gammie JS, O'Brien SM, Griffith BP, et al.Surgical treatment of mitral valve endocarditis in North America[J].Ann Thorac Surg, 2005, 80:2199-2204. doi: 10.1016/j.athoracsur.2005.05.036 [8] Hill EE, Herregods MC, Vanderschueren S, et al.Outcome of patients requiring valve surgery during active infective endocarditis[J].Ann Thorac Surg, 2008, 85:1564-1570. doi: 10.1016/j.athoracsur.2008.02.014 [9] David TE, Gavra G, Feindel CM, et al.Surgical treatment of active infective endocarditis:a continued challenge[J].J Thorac Cardiovasc Surg, 2007, 133:144-149. doi: 10.1016/j.jtcvs.2006.08.060 [10] Ruttmann E, Legit C, Poelzl G, et al.Mitral valve repair provides improved outcome over replacement in active infective endocarditis[J].J Thorac Cardiovasc Surg, 2005, 130:765-771. doi: 10.1016/j.jtcvs.2005.03.016 [11] Sabik JF, Lytle BW, Blackstone EH, et al.Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis[J].Ann Thorac Surg, 2002, 74:650-659. doi: 10.1016/S0003-4975(02)03779-7 [12] Obadia JF, Henaine R, Bergerot C, et al.Monobloc aortomitral homograft or mechanical valve replacement:a new surgical option for extensive bivalvular endocarditis[J].J Thorac Cardiovasc Surg, 2006, 131:243-245. doi: 10.1016/j.jtcvs.2005.05.058 [13] Avierinos JF, Thuny F, Chalvignac V, et al.Surgical treatment of active aortic endocarditis:homografts are not the cornerstone of outcome[J].Ann Thorac Surg, 2007, 84:1935-1942. doi: 10.1016/j.athoracsur.2007.06.050 [14] Piper C, Wiemer M, Schulte HD, et al.Stroke is nota contraindication for urgent valve replacement in acute infective endocarditis[J].J Heart Valve Dis, 2001, 10:703-711. http://europepmc.org/abstract/MED/11767174 [15] Gillinov AM, Shah RV, Curtis WE, et al.Valve replacement in patients with endocarditis and acute neurologic deficit[J].Ann Thorac Surg, 1996, 61:1125-1129. doi: 10.1016/0003-4975(96)00014-8 [16] Hill EE, Hurijgers P, Herregods MC, etal.Evolving trends in infective endocarditis[J].Clin Microbiol Infect, 2006, 12:5-12. doi: 10.1111/j.1469-0691.2005.01289.x [17] Miro JM, Anguera I, Cabell CH, et al.Staphylococcus aureus native valve infective endocarditis:report on 566 episodes from the International Collaboration on Endocarditis[J].Clin Infect Dis, 2005, 41:507-514. doi: 10.1086/431979